补铁剂研究进展

被引：39

作者：

王方海 ^{[1
,2
]}

赵维 ^{[1
]}

陈建芳 ^{[1
]}

唐伟方 ^{[2
]}

秦勇 ^{[1
]}

机构：

[1] 江苏神龙药业有限公司

[2] 中国药科大学理学院

来源：

药学进展 | 2016年 / 40卷 / 09期

关键词：

缺铁性贫血; 多糖铁复合物; 补铁剂; 静脉铁剂;

D O I：

暂无

中图分类号：

R973 [血液和造血系统药物];

学科分类号：

1007 ;

摘要：

缺铁性贫血是全球最常见的一种营养素缺乏疾病,患者由于血氧不足,易引起疲劳、烦躁、记忆力减退等系列症状,严重影响身体健康,降低了生活质量。补铁剂是目前最广谱有效的预防和治疗缺铁性贫血的药物。综述补铁剂的发展历程,在铁吸收代谢机制的基础上,归纳总结传统铁剂的特点和类别,同时对高分子铁剂的结构信息、理化性质、给药途径和剂量、吸收机制等进行系统整理,介绍3种即将进入我国市场的新型静脉铁剂的使用和临床试验情况,为补铁剂的研究提供参考。

引用

页码：680 / 688

页数：9

共 21 条

[1] Hepcidin的生物学效应 [J].

孙明月 ;

郭春雨 ;

潘玉婷 ;

王琳 ;

殷惠军 .

医学研究杂志, 2014, 43 (11) :150-153

[2] 缺铁性贫血及补铁剂研究进展 [J].

杨真 ;

罗海吉 .

国外医学(卫生学分册), 2006, (02) :90-93

[3] Deficiencies in the Management of Iron Deficiency Anemia During Childhood [J].

Powers, Jacquelyn M. ;

Daniel, Catherine L. ;

McCavit, Timothy L. ;

Buchanan, George R. .

PEDIATRIC BLOOD & CANCER, 2016, 63 (04) :743-745

[4] Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women [J].

Moretti, Diego ;

Goede, Jeroen S. ;

Zeder, Christophe ;

Jiskra, Markus ;

Chatzinakou, Vaiya ;

Tjalsma, Harold ;

Melse-Boonstra, Alida ;

Brittenham, Gary ;

Swinkels, Dorine W. ;

Zimmermann, Michael B. .

BLOOD, 2015, 126 (17) :1981-1989

[5]

Iron sucrose – characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas[J] . Yves Beguin,Aur&eacute,lie Jaspers.Expert Opinion on Pharmacotherapy . 2014 (14)

[6] Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia [J].

Dossabhoy, Neville R. ;

Turley, Steven ;

Gascoyne, Rebecca ;

Tapolyai, Mihaly ;

Sulaiman, Karina .

RENAL FAILURE, 2014, 36 (07) :1033-1037

[7]

A Phase III, randomized, open‐label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy[J] . David Hetzel,William Strauss,Kristine Bernard,Zhu Li,Audrone Urboniene,Lee F. Allen.Am. J. Hematol. . 2014 (6)

[8]

Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD)[J] . S. Fütterer,I. Andrusenko,U. Kolb,W. Hofmeister,P. Langguth.Journal of Pharmaceutical and Biomedical Analysis . 2013

[9] The regulation of iron metabolism in the mononuclear phagocyte system [J].

Kong, Wei-Na ;

Lei, Yu-Hua ;

Chang, Yan-Zhong .

EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) :411-418

[10] Comparative rates of adverse events with different formulations of intravenous iron [J].

Okam, Maureen M. ;

Mandell, Elyse ;

Hevelone, Nathanael ;

Wentz, Rachel ;

Ross, Ainsley ;

Abel, Gregory A. .

AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (11) :E123-E124

← 1 2 3 →